Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jul;35(7):858-864.
doi: 10.1038/s41379-022-01052-4. Epub 2022 Mar 7.

Should screening for cervical cancer go to primary human papillomavirus testing and eliminate cytology?

Mohammed Amer Swid  1 , Sara E Monaco  2
Affiliations
Free article
Review

Should screening for cervical cancer go to primary human papillomavirus testing and eliminate cytology?

Mohammed Amer Swid et al. Mod Pathol. 2022 Jul.
Free article

Abstract

This review will systematically highlight the pros and cons of cervical cancer screening with HPV (human papillomavirus) testing and cytological methods (Papanicolaou (Pap) test). When comparing the screening modalities, various facets will be addressed, such as cost effectiveness, and harms and benefits across different demographics and age groups. It is important to note that due to the expansive variance in material costs, practices, and resource availability across different geographical regions, these comparisons are far from straight forward, and ultimately make it challenging to render definitive global recommendations. Thus, the intent of this review is to highlight some of the differences in difference cervical cancer screening modalities that can help one to choose an optimal screening method in their specific situation.

PubMed Disclaimer

References

    1. Chrysostomou, A. C., Stylianou, D. C., Constantinidou, A. & Kostrikis, L. G. Cervical cancer screening programs in Europe: The transition towards HPV vaccination and population-based HPV testing. Viruses 10, 729 (2018). - DOI
    1. Diamantis, A., Magiorkinis, E. & Androutsos, G. What’s in a name? Evidence that Papanicolaou, not Babes, deserves credit for the Pap test. Diagn Cytopathol 38, 473–476 (2010). - DOI
    1. Lees, B. F., Erickson, B. K. & Huh, W. K. Cervical cancer screening: evidence behind the guidelines. Am J Obstet Gynecol 214, 438–443 (2016). - DOI
    1. Chang, S., Xu, H., Zhang, L. & Qiao, Y. Cervical cancer: epidemiology, risk factors and screening. Chin J Cancer Res 32, 720–728 (2020). - DOI
    1. Gaffney, D. K., Hashibe, M., Kepka, D., Maurer, K. A. & Werner, T. L. Too many women are dying from cervix cancer: problems and solutions. Gynecol Oncol 151, 547–554 (2018). - DOI